Development of Potent Pf CLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
基于 TCMDC-135051 的强效 Pf CLK3 抑制剂作为新型抗疟药的开发
期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.0c00451
Amit Mahindra, Omar Janha, Kopano Mapesa, Ana Sanchez-Azqueta, Mahmood M Alam, Alfred Amambua-Ngwa, Davis C Nwakanma, Andrew B Tobin, Andrew G Jamieson